Description
KLOW Blend — 80mg
KLOW Blend combines four compounds investigated in experimental models of cellular regulation, extracellular matrix biology, and inflammatory signaling.
Composition per vial
- GHK-Cu — 50mg
- BPC-157 — 10mg
- TB-500 — 10mg
- KPV — 10mg
GHK-Cu is studied in copper-dependent cellular processes and extracellular matrix signaling. BPC-157 and TB-500 are investigated in tissue-associated models. KPV is a lysine-proline-valine tripeptide studied in inflammatory and epithelial signaling. TB-500 identity should be confirmed by peptide sequence documentation. The combined formulation requires independent characterization; individual-component findings do not establish combined efficacy or safety.
Total nominal content: 80mg.
FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
